10 steps to succesfully navigating your next clinical trial
Undertaking Phase 1 clinical trials in Australia during a time of uncertainty.
Statement on Coronavirus/COVID-19
Nucleus Network acquires majority shareholding in US-based Prism Clinical Research
Nucleus Network expansion creates first global, multi-site early phase trial organization with investment in USA-based phase I clinical trials organisation, Prism Clinical Research.
Studies Approved within 4-5 weeks of IRB Submission
Australia’s Clinical Trial regulatory process doesn’t require an IND or IMP
Record Audit Performance
Our facilities and processes have been FDA & EMA Inspected and previously ANVISA Certified
Financial Incentives for R&D in Australia
Take advantage of Australia’s favourable exchange rates and internationally-accessible R&D Incentive Scheme
Melbourne, Australia: Culturally Diverse and Highly Innovative
Over 140 cultures represented, and some of the best healthcare in the world, makes our city a top destination for Clinical Trials
Our Reputation is Driven by Repeat Business
Learn why we are the most trusted Phase I Clinical Trials facility in Australia
Learn more about conducting Clinical Trials with Nucleus Network